Global Status of Commercialized Biotech Crops. International Service for the Acquisition of Agri-biotech Applications

Transcription

1

2 Global Status of Commercialized Biotech Crops International Service for the Acquisition of Agri-biotech Applications

3 Outline of Presentation Introduction Global Perspective and Status Trends and Indicators Challenges and Potentials

4 A Global Food, Feed and Fiber Strategy No single approach will provide solution to food, feed and fiber security Conventional crop improvement alone will not double food production by biotech crops not a panacea but essential Successful strategy must have multiple approaches that address all the principal issues that include: Population control Improved food distribution systems The technology component - A crop improvement strategy that integrates conventional and biotech crop approaches to optimize productivity and that can contribute to food, feed and fiber security

5 Crop Productivity Opportunities Percentage Current crop production Germplasm improvement Farm practices Land gain Others post harvest losses processing efficiency Potential crop production Adapted from CroplifeAsia

6 Stakeholder Perception of GMOs in Developing Countries Importance of problems in agriculture How GM technology can help solve the problems Source: Aerni and Bernauer, 2006

7 Global Perspective and Status

8 Commercialized Biotech Crops Global Area

9 Biotech Crop Adopters

10 Commercialized Biotech Crops by Principal Crop

11 Commercialized Biotech Crops by Trait

12 Global Farm Income Benefits Trait 2004 increase in farm income (US$M) increase in farm income (US$M) HT soybean 2,440 9,300 HT maize HT cotton HT canola IR maize 415 1,932 IR cotton 1,472 5,726 Others Total 4,779 19,037 Source: Brooks and Barfoot 2005 GM Crops: The Global Economic and Environmental Impact: The First Nine Years

13 Regulatory Approvals (2006) Number of Events Crop USA Canada EU Japan Aus China Mexico SAfrica Phils Maize Canola Cotton Soybean Tomato Wheat Potato Sugarbeet Rice Other crops Total Source of data: AGBIOS 2006

14 Regulatory Approvals (2006) Crops Events Traits Maize 33 IR, HT, IR/HT, NV Canola 17 HT, NV Cotton 13 IR, HT, IR/HT Soybean 7 HT, NV Tomato 6 IR, DR Wheat 5 HT Potato 4 IR, HT, IR/VR Sugarbeet 3 HT Rice 2 HT Other crops 15 IR insect resistance, HT herbicide tolerance, NV nutritional value, DR delayed ripening, VR virus resistance Source of data: AGBIOS 2006

15 Trends and Indicators

16 Biotech Crops Regulatory Footprint, 2005 Actively granting approvals Pre-commercial field trials Commercialization delayed

17 Global R&D Diffusion R&D activity has been immense and much wider than commercial adoption 63 countries with biotech production or research activity 57 crops of biotech research interest Field crops: 16 in 55 countries Vegetables: 14 in 50 countries Fruits: 16 in 29 countries Other crops: 11 in 29 countries Source: Runge 2005

18 Diversity of Crops 57 fruits, vegetables, field crops and other plants ranging from lab trials to commercial production 16 Field Crops Alfalfa Barley Canola Cassava Clover Cotton Flax Maize Rice Safflower Sorghum Soybean Sugar Beet Sugar Cane Sunflower Wheat 14 Vegetables Broccoli Cabbage Carrot Cauliflower Cucumber Eggplant Lettuce Onion Pea/Bean Pepper Potato Spinach Squash Tomato 16 Fruits Apple Banana Cantaloupe Cherry Citrus Coconut Grape Kiwi Mango Melon Papaya Pineapple Plum Raspberry Strawberry Watermelon 11 Other Crops Chicory Cocoa Coffee Garlic Lupins Mustard Oil Palm Oilseed Poppy Olive Peanut Tobacco Source: Runge 2005

19 Biotech Crop Field Trials, , USA and EU EU USA data as of August for USA and May for EU EU data: USA data:

20 Total Number of Approvals for Field Trials in the US by trait by year Source: ISB-VT, 2006

21 Products Further Down the Road plant-made industrial products (PMIPs) and plant-made pharmaceuticals (PMPs) bioenergy sources crops tolerant to drought, water logging, salts, heavy metals, heat and cold safer food, improved nutritional value, enhanced taste, better fiber quality, longer shelf-life

22 Challenges and Potentials

23 Challenges to Commercialization Market resistance/uncertainties Consumer acceptance Public perception of risks and benefits Market size and value Freedom to operate Regulatory issues Data requirements Costs of compliance

24 Potentials for Developing Countries More than half of the 63 countries engaged in biotech R&D are in the developing world China is aggressively engaged with huge investment annually India has at least 20 academic and research institutions involved in R&D Argentina and Brazil are rapid adopters and poised for further growth New legislation, regulations and commercial agreements coming into place in Latin America and Asia Brazil, South Africa, Paraguay, Egypt, Philippines most supportive of biotech crop development

25 Challenges for the Future Continuing responsible stewardship assessment of risks, with and without biotech crops Improved communication with society knowledgebased decisions re biotech crops Increase in number of adopters and area Ensure that biotech crops in conjunction with conventional technologies can contribute to a more sustainable agriculture, global food, feed and fiber security, alleviation of poverty, and safer environment

26 THANK YOU INTERNATIONAL SERVICE FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS